Authors: SHAH VP YACOBI A BARR WH BENET LZ BREIMER D DOBRINSKA MR ENDRENYI L FAIRWEATHER W GILLESPIE W GONZALEZ MA HOOPER J JACKSON A LESKO LJ MIDHA KK NOONAN PK PATNAIK R WILLIAMS RL

Citation: Vp. Shah et al., EVALUATION OF ORALLY-ADMINISTERED HIGHLY VARIABLE DRUGS AND DRUG FORMULATIONS, Pharmaceutical research, 13(11), 1996, pp. 1590-1594

Authors: SCHNEIDER JA CLARK KF GREENE AA REISCH JS MARKELLO TC GAHL WA THOENE JG NOONAN PK BERRY KA

Citation: Ja. Schneider et al., RECENT ADVANCES IN THE TREATMENT OF CYSTINOSIS, Journal of inherited metabolic disease, 18(4), 1995, pp. 387-397

Authors: TERESI ME RIGGS CE WEBSTER PM ADAMS MJ NOONAN PK ODONNELL JP

Citation: Me. Teresi et al., BIOEQUIVALENCE OF 2 METHOTREXATE FORMULATIONS IN PSORIATIC AND CANCER-PATIENTS, The Annals of pharmacotherapy, 27(12), 1993, pp. 1434-1438

Authors: NERELLA NG BLOCK LH NOONAN PK

Citation: Ng. Nerella et al., THE IMPACT OF LAG TIME ON THE ESTIMATION OF PHARMACOKINETIC PARAMETERS .1. ONE-COMPARTMENT OPEN MODEL, Pharmaceutical research, 10(7), 1993, pp. 1031-1036